# UNIVERSITY OF COLORADO DENVER: Pediatric acute lymphoblastic leukemia: Improving outcomes through incorporation of novel targeted therapies into treatment for relapsed and newly diagnosed disease

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF COLORADO DENVER |
| Location | Aurora, CO |
| Project | Pediatric acute lymphoblastic leukemia: Improving outcomes through incorporation of novel targeted therapies into treatment for relapsed and newly diagnosed disease |
| Project number | 5R50CA288324-03 |
| Mechanism | R50 |
| Institute | National Cancer Institute |
| Award | $172,013 |
| Awarded | 2026-09-02 |
| Project period | 2024-09-19 to 2029-08-31 |
| UEI | MW8JHK6ZYEX8 |

## Why this score
- Award of $172,013.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11399083). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.